Benzocaine 60 MG/ML / isopropyl alcohol 0.654 ML/ML Medicated Pad — RxCUI 2700214
RxNorm drug concept · Semantic clinical drug
RxCUI 2700214
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2700214
Official nameBenzocaine 60 MG/ML / isopropyl alcohol 0.654 ML/ML Medicated Pad
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbenzocaine 6 % / isopropyl alcohol 65.4 % Medicated Pad
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Benzocaine 60 MG/ML / isopropyl alcohol 0.654 ML... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Benzocaine 60 MG/ML / isopropyl alcohol 0.654 ML/ML Medicated Pad
RxCUI 2700214 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Benzocaine
1399IN -
Isopropyl alcohol
797541IN -
Benzocaine / isopropyl alcohol
1006916MIN
-
Benzocaine
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Benzocaine / isopropyl alcohol Medicated Pad
808358SCDF -
Benzocaine / isopropyl alcohol Medicated Pad or Tape
1152352SCDG -
Benzocaine / isopropyl alcohol Topical Product
1152353SCDG -
Medicated Pad
797271DF -
Medicated Pad or Tape
1151124DFG -
Topical Product
1151122DFG
-
Benzocaine / isopropyl alcohol Medicated Pad
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Benzocaine 60 MG/ML
358442SCDC -
Isopropyl alcohol 0.654 ML/ML
2700213SCDC
-
Benzocaine 60 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Benzocaine 60 MG/ML
SCDC · 358442 -
Isopropyl alcohol 0.654 ML/ML
SCDC · 2700213 -
Benzocaine / isopropyl alcohol Medicated Pad
SCDF · 808358 -
Benzocaine / isopropyl alcohol Medicated Pad or Tape
SCDG · 1152352 -
Benzocaine / isopropyl alcohol Topical Product
SCDG · 1152353
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2700214 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 61333-0215-01 | 100 PATCH in 1 BOX (61333-215-01) / .8 mL in 1 PATCH | LIGHTS Instant Sting Relief Pad | Lights Medical Manufacture Co., Ltd. | 2024-12-06 |
Observed labelers:
Lights Medical Manufacture Co., Ltd. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.